Mazumdar Shaw’s Mission to Expand Access to Vital Drugs

AI Summary

Kiran Mazumdar-Shaw, known as India’s 'Queen of Biotech,' discusses her journey building Biocon into a major global insulin and biosimilars producer. She highlights her mission to expand access to vital drugs and emphasizes India’s need to prepare for an AI-driven future.

Known as India’s ‘Queen of Biotech’, Kiran Mazumdar-Shaw built Biocon from a rented garage almost 50 years ago. Today, her multibillion-dollar company is one of the world’s biggest producers of insulin, and a leading force in biosimilars. As she looks at handing over her life’s work to successors, Mazumdar-Shaw talks to Bloomberg’s Haslinda Amin about her pioneering journey as a female entrepreneur in India, her mission to deliver life-saving therapies to patients and what she believes India must do to tackle an AI future. (Source: Bloomberg)